Ann: Strategic Review Update - Further Information, page-8

  1. 1,599 Posts.
    lightbulb Created with Sketch. 547
    35mil minis 18 mil dept is 17mill in cash they will hold.

    Then 7.35 mil incoming: "plus an uncappedcontingent consideration comprised of a three-year earn-out based on theperformance of the Target Group in the three year period after completion."

    = 24 mil and no dept.

    I would advise to keep plenty of dept restructured at lower rates! Cash will be king as interest rates drop and liquidity runs out!
    (I just remortgaged all my houses for a 1 mil 25 years OD - as that will be impossible in 12 months)

    It is not anticipated that theproceeds of sale will be utilised in the Company's US business. hmm. Possible pay out to shareholders.

    Big drug company wanting to front run MDR for spruking their products I would suspect.
    If that test run pans out, they would be after the US market too which could be the big bucks.

    Only getting the Aussie IP..?
    "which outlines a proposal to acquire the Company's ANZ business divisionand associated intellectual property for cash considerations"


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
7.9¢
Change
-0.001(1.25%)
Mkt cap ! $49.39M
Open High Low Value Volume
8.0¢ 8.0¢ 7.9¢ $37.74K 476.6K

Buyers (Bids)

No. Vol. Price($)
2 230316 7.9¢
 

Sellers (Offers)

Price($) Vol. No.
8.1¢ 18172 2
View Market Depth
Last trade - 15.32pm 23/07/2025 (20 minute delay) ?
MDR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.